Conference
A phase II study of RO4929097 (RO), a gamma-secretase inhibitor, in advanced platinum (Pt)-resistant (R) ovarian cancer (OC): A study of the PMH, Chicago, and California phase II consortia
Authors
Diaz-Padilla I; Clarke BA; Hirte HW; Welch S; Mackay H; Biagi JJ; Reedijk M; Weberpals JI; Fleming GF; Wang L
Volume
30
Publisher
AMER SOC CLINICAL ONCOLOGY
Publication Date
May 20, 2012
Name of conference
48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)
Conference place
Chicago, IL
Conference start date
June 1, 2012
Conference end date
June 6, 2012
Conference proceedings
JOURNAL OF CLINICAL ONCOLOGY
Issue
15
ISSN
0732-183X